AI-Enhanced Healthcare: Integrating ChatGPT-4 in ePROs for Improved Oncology Care and Decision-Making: A Pilot Evaluation.

Journal: Current oncology (Toronto, Ont.)
PMID:

Abstract

BACKGROUND: Since 2023, ChatGPT-4 has been impactful across several sectors including healthcare, where it aids in medical information analysis and education. Electronic patient-reported outcomes (ePROs) play a crucial role in monitoring cancer patients' post-treatment symptoms, enabling early interventions. However, managing the voluminous ePRO data presents significant challenges. This study assesses the feasibility of utilizing ChatGPT-4 for analyzing side effect data from ePROs.

Authors

  • Chihying Liao
    Department of Radiation Oncology, China Medical University Hospital, Taichung City 404, Taiwan.
  • Chinnan Chu
    Department of Radiation Oncology, China Medical University Hospital, Taichung City 404, Taiwan.
  • Mingyu Lien
    Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung City 404, Taiwan.
  • Yaochung Wu
    Department of Surgery, China Medical University Hospital, Taichung City 404, Taiwan.
  • Tihao Wang
    Department of Radiation Oncology, China Medical University Hospital, Taichung City 404, Taiwan.